Flexicath Ltd., an Israeli company, has obtained FDA clearance to market its version of PICC line (peripherally inserted central catheter) that offers an ability to insert the catheter from inside a specially designed sleeve:
The FirmGrip™ combines a standard catheter enclosed in a polymer sleeve with a special silicone insertion unit to produce a self-contained sterile catheter insertion field.
In this model, a soft midterm catheter (20 cm) encased in the compact sterile sleeve is inserted in a simple, efficient manner using Peel-away needle or standard IV canula as port of entry. Having the midterm catheter encased in the sterile sleeve reduces the chance of infection and the need for an external sterile environment. FirmGrip.15 provides physicians the flexibility to leave a soft catheter in place for midterm (up to 29 days) treatment periods.
AdvantagesSolution for midterm treatment (up to 29 days) Reduced risk of infection and touch contamination – Removes risk of glove powder contamination
– Eliminates chance of airborne pathogens accessing the catheterReduced insertion time with a simplified procedure Significantly lower procedure costs, with less staff time for preparation Safer, more accurate insertion technique Flexible treatment options
Product page…
Globes [online]: Flexicath receives FDA approval for first product …
